G

GALT

Galectin Therapeutics Inc

4.18

Jul 17 • 03:59PM ET -0.05 (-1.18%)

4.24

Aftermarket • 06:18PM ET +0.06 (1.56%)

Healthcare Biotechnology USA Micro NASD

Peers: AGEN CNTB IMUX KZIA SPRO VRCA MOLN HURA ORMP PLX

| Held by: VTI IWM VXF IWO VTWO IWC IWN MEDX VTWG RSSL

Scroll to Statements

Index	RUT
Market Cap	274.95M
Enterprise Value	398.76M
Income	-26.44M
Sales	0.00M
Book/sh	-2.01
Cash/sh	0.21
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	9
IPO	Sep 04, 2002

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	-
P/C	19.49
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	2.15
Current Ratio	2.15
Debt/Eq	-
LT Debt/Eq	-
Option/Short	Yes / Yes

EPS (ttm)	-0.41
EPS next Y	-0.33
EPS next Q	-0.09
EPS this Y	22.92%
EPS next Y	10.81%
EPS next 5Y	-
EPS past 3/5Y	9.53% -3.21%
Sales past 3/5Y	- -
EPS Y/Y TTM	43.38%
Sales Y/Y TTM	-
EPS Q/Q	49.34%
Sales Q/Q	-
Earnings	May 15 BMO
EPS/Sales Surpr.	-33.33% -

Insider Own	28.73%
Insider Trans	-0.56%
Inst Own	21.06%
Inst Trans	6.21%
ROA	-207.62%
ROE	-
ROIC	-479.65%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-2.47%
SMA50	32.16%
SMA200	12.60%
Trades

Shs Outstand	65.86M
Shs Float	46.93M
Short Float	19.12%
Short Ratio	14.05
Short Interest	8.97M
52W High	7.13 -41.44%
52W Low	2.03 106.17%
Volatility	14.65% 13.72%
ATR (14)	0.47
RSI (14)	52.89
Beta	0.38
Rel Volume	0.65
Avg Volume	638.76K
Volume	413,756

Perf Week	2.83%
Perf Month	58.14%
Perf Quarter	84.73%
Perf Half Y	39.17%
Perf YTD	0.36%
Perf Year	44.46%
Perf 3Y	122.07%
Perf 5Y	56.95%
Perf 10Y	174.67%
Recom	1.00
Target Price	11.00
Prev Close	4.22
Price	4.18
Change	-1.18%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)